1887
News Open Access
Like 0
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2016.21.6.30134
2016-02-11
2021-09-16
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2016.21.6.30134
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/21/6/eurosurv-21-30134-4.html?itemId=/content/10.2807/1560-7917.ES.2016.21.6.30134&mimeType=html&fmt=ahah

References

  1. Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE). Interim 2015-16 influenza vaccine effectiveness results, I-MOVE multicentre case-control study. I-MOVE; 2016. Available from: https://sites.google.com/site/epiflu/Home/2015-16-interim-results
  2. European Centre for Disease Prevention and Control (ECDC). Protocol for case control studies to measure pandemic and seasonal vaccine effectiveness in the European Union and European Economic Area. Stockholm: ECDC; 2010. Available from: http://www.ecdc.europa.eu/en/publications/Publications/0907_TED_Influenza_AH1N1_Measuring_Influenza_Vaccine_Effectiveness_Protocol_Case_Control_Studies.pdf
  3. Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE). I-MOVE website list of publications 2007-2015. I-MOVE; 2016. Available from: https://sites.google.com/site/epiflu/list-of-i-move-publications
  4. European Centre for Disease Prevention and Control (ECDC). Risk Assessment: Seasonal influenza 2015-16 in the EU/EEA countries. Stockholm: ECDC; 2016. Available from: http://ecdc.europa.eu/en/publications/Publications/seasonal-influenza-risk-assessment-2015-2016.pdf
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error